药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Solifenacin
Enrofloxacin
Zinc chloride can cause a decrease in the absorption of Enrofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Solifenacin
Flumequine
Zinc chloride can cause a decrease in the absorption of Flumequine resulting in a reduced serum concentration and potentially a decrease in efficacy.
Solifenacin
Nemonoxacin
Zinc chloride can cause a decrease in the absorption of Nemonoxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Solifenacin
Garenoxacin
Zinc chloride can cause a decrease in the absorption of Garenoxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Solifenacin
Technetium Tc-99m ciprofloxacin
Zinc chloride can cause a decrease in the absorption of Technetium Tc-99m ciprofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Solifenacin
Fleroxacin
Zinc chloride can cause a decrease in the absorption of Fleroxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Solifenacin
Deferasirox
Zinc chloride can cause a decrease in the absorption of Deferasirox resulting in a reduced serum concentration and potentially a decrease in efficacy.
Solifenacin
Deferiprone
Zinc chloride can cause a decrease in the absorption of Deferiprone resulting in a reduced serum concentration and potentially a decrease in efficacy.
Solifenacin
Raltegravir
Zinc chloride can cause a decrease in the absorption of Raltegravir resulting in a reduced serum concentration and potentially a decrease in efficacy.
Quazepam
Ferric derisomaltose
The absorption of Tetraferric tricitrate decahydrate can be decreased when combined with Ferric derisomaltose.
Quazepam
Technetium Tc-99m oxidronate
Tetraferric tricitrate decahydrate can cause a decrease in the absorption of Technetium Tc-99m oxidronate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Quazepam
Phosphate ion
Tetraferric tricitrate decahydrate can cause a decrease in the absorption of Phosphate ion resulting in a reduced serum concentration and potentially a decrease in efficacy.
Quazepam
Ferric pyrophosphate citrate
Tetraferric tricitrate decahydrate can cause a decrease in the absorption of Ferric pyrophosphate citrate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Quazepam
Sodium tripolyphosphate
Tetraferric tricitrate decahydrate can cause a decrease in the absorption of Sodium tripolyphosphate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Quazepam
Dipotassium phosphate
Tetraferric tricitrate decahydrate can cause a decrease in the absorption of Dipotassium phosphate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Quazepam
Monopotassium phosphate
Tetraferric tricitrate decahydrate can cause a decrease in the absorption of Monopotassium phosphate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Quazepam
Ferric pyrophosphate
Tetraferric tricitrate decahydrate can cause a decrease in the absorption of Ferric pyrophosphate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Quazepam
Geranylgeranyl diphosphate
Tetraferric tricitrate decahydrate can cause a decrease in the absorption of Geranylgeranyl diphosphate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Quazepam
OXI-4503
Tetraferric tricitrate decahydrate can cause a decrease in the absorption of OXI-4503 resulting in a reduced serum concentration and potentially a decrease in efficacy.
Quazepam
Pyrophosphoric acid
Tetraferric tricitrate decahydrate can cause a decrease in the absorption of Pyrophosphoric acid resulting in a reduced serum concentration and potentially a decrease in efficacy.